Clinical Characteristics and Risk Factors of Patients with Flupirtine-induced Liver Cirrhosis Complicated with Upper Gastrointestinal Bleeding

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2021 Jun 21

PMID 34150161

Citations 1

Authors

Mengjun Zhang

Si Huang

Na Ye

Xuehong Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate clinical characteristics and risk factors of patients with Flupirtine-induced liver cirrhosis complicated with upper gastrointestinal bleeding.

Methods: A total of 116 patients with liver cirrhosis admitted to our hospital from July 2018 to July 2019 were selected and divided into bleeding group (liver cirrhosis complicated with upper gastrointestinal bleeding, n = 71) and non-bleeding group (liver cirrhosis, n = 45). The clinical data of patients in the two groups were collected, including general data, liver function, urinalysis, coagulation function and imaging data. Univariate analysis and multivariate logistic regression analysis were utilized to find the influencing factors of liver cirrhosis complicated with upper gastrointestinal bleeding.

Results: Of the 116 patients, 45 patients had upper gastrointestinal bleeding, with an incidence rate of 38.79%, including 18 patients (40.00%) with rupture of esophageal varices, 9 (20.00%) with rupture of gastric varices, 9 (20.00%) of portal hypertensive gastropathy, 8 (17.78%) with peptic ulcer, 1 (2.22%) with acute erosive hemorrhagic gastritis; 14 (31.11%) experienced recurrent hemorrhage within 72 hours after treatment, but no death occurred. There were 45 cases (38.79%) in the bleeding group, and 71 (61.21%) in the non-bleeding group, and the differences in the course of liver cirrhosis, the degree of esophageal varices, peptic ulcer, portal hypertension, non-steroidal drug medication and TP between the bleeding group and non-bleeding group were significant (P < 0.05). Severe esophageal varices, liver cirrhosis, peptic ulcer, portal hypertension, non-steroidal drug medication, and TP ≥ 16 s were found to be risk factors of liver cirrhosis complicated with upper gastrointestinal bleeding by logistic regression analysis.

Conclusion: Clinically, it is necessary to take corresponding intervention measures to reduce the incidence of upper gastrointestinal bleeding in patients with liver cirrhosis and improve the prognosis of patients with liver cirrhosis.

Citing Articles

Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study.

Lu D, Jiang Z, Zhai X, Sun Z Comput Math Methods Med. 2022; 2022:2566746.

PMID: 35966248 PMC: 9371864. DOI: 10.1155/2022/2566746.

References

Guevara M, Fernandez-Esparrach G, Alessandria C, Torre A, Terra C, Montana X . Effects of contrast media on renal function in patients with cirrhosis: a prospective study. Hepatology. 2004; 40(3):646-51. DOI: 10.1002/hep.20373. View

Nojkov B, Cappell M . Distinctive aspects of peptic ulcer disease, Dieulafoy's lesion, and Mallory-Weiss syndrome in patients with advanced alcoholic liver disease or cirrhosis. World J Gastroenterol. 2016; 22(1):446-66. PMC: 4698507. DOI: 10.3748/wjg.v22.i1.446. View

Kim M, Jeong W, Baik S . Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol. 2014; 20(15):4300-15. PMC: 3989965. DOI: 10.3748/wjg.v20.i15.4300. View

Tandon P, Bishay K, Fisher S, Yelle D, Carrigan I, Wooller K . Comparison of clinical outcomes between variceal and non-variceal gastrointestinal bleeding in patients with cirrhosis. J Gastroenterol Hepatol. 2018; 33(10):1773-1779. DOI: 10.1111/jgh.14147. View

Huang L, Yu Q, Wang J . Association Between Changes in Splanchnic Hemodynamics and Risk Factors of Portal Venous System Thrombosis After Splenectomy with Periesophagogastric Devascularization. Med Sci Monit. 2018; 24:4355-4362. PMC: 6048999. DOI: 10.12659/MSM.909403. View

Ardevol A, Ibanez-Sanz G, Profitos J, Aracil C, Castellvi J, Alvarado E . Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. Hepatology. 2017; 67(4):1458-1471. DOI: 10.1002/hep.29370. View

Khamaysi I, Gralnek I . Acute upper gastrointestinal bleeding (UGIB) - initial evaluation and management. Best Pract Res Clin Gastroenterol. 2013; 27(5):633-8. DOI: 10.1016/j.bpg.2013.09.002. View

Matsumoto R, Uchida K, Nishida S, Island E, Levi D, Fan J . Extra-anatomical Meso-portal Venous Jump Graft Repair for Early Portal Vein Thrombosis After Liver Transplant in an Infant With a Hypoplastic Portal Vein: A Case Report. Transplant Proc. 2016; 48(9):3186-3190. DOI: 10.1016/j.transproceed.2016.08.031. View

Tahiri M, Drighil A, Jalal Y, Ghellab D, Hliwa W, Fouad H . Chronic permanent hypoxemia predisposes to mild elevation of liver stiffness. World J Gastroenterol. 2014; 20(30):10564-9. PMC: 4130867. DOI: 10.3748/wjg.v20.i30.10564. View

10.

Gibson W, Scaturo N, Allen C . Acute Management of Upper Gastrointestinal Bleeding. AACN Adv Crit Care. 2018; 29(4):369-376. DOI: 10.4037/aacnacc2018644. View

11.

Tantemsapya N, Superina R, Wang D, Kronauer G, Whitington P, Melin-Aldana H . Hepatic Histology and Morphometric Measurements in Idiopathic Extrahepatic Portal Vein Thrombosis in Children, Correlated to Clinical Outcome of Meso-Rex Bypass. Ann Surg. 2017; 267(6):1179-1184. DOI: 10.1097/SLA.0000000000002128. View

12.

Abbas Z, Yakoob J, Usman M, Shakir T, Hamid S, Jafri W . Effect of Helicobacter pylori and its virulence factors on portal hypertensive gastropathy and interleukin (IL)-8, IL-10, and tumor necrosis factor-alpha levels. Saudi J Gastroenterol. 2014; 20(2):120-7. PMC: 3987152. DOI: 10.4103/1319-3767.129477. View

13.

Zhang W, Gong H, Su Z, Zhang X, Cao S . Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study. Medicine (Baltimore). 2019; 98(31):e16628. PMC: 6708998. DOI: 10.1097/MD.0000000000016628. View

14.

Cerini F, Martinez Gonzalez J, Torres F, Puente A, Casas M, Vinaixa C . Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study. Hepatology. 2015; 62(2):575-83. DOI: 10.1002/hep.27783. View

15.

Nishikawa H, Osaki Y . Liver Cirrhosis: Evaluation, Nutritional Status, and Prognosis. Mediators Inflamm. 2015; 2015:872152. PMC: 4606163. DOI: 10.1155/2015/872152. View

16.

Tsochatzis E, Bosch J, Burroughs A . Liver cirrhosis. Lancet. 2014; 383(9930):1749-61. DOI: 10.1016/S0140-6736(14)60121-5. View

17.

Nephew L, Goldberg D . Impact of Anticoagulation on Upper Gastrointestinal Bleeding in Cirrhosis. Gastroenterology. 2016; 150(5):1239-1241. DOI: 10.1053/j.gastro.2016.03.024. View

18.

Wei X, Xu J, Li N, Yu Y, Shi J, Guo W . The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus. HPB (Oxford). 2016; 18(3):287-95. PMC: 4814596. DOI: 10.1016/j.hpb.2015.10.007. View

19.

Mayorga C, Rockey D . Clinical utility of a standardized electronic order set for the management of acute upper gastrointestinal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2013; 11(10):1342-8. DOI: 10.1016/j.cgh.2013.04.021. View

20.

Abd-Elsalam S, Habba E, Elkhalawany W, Tawfeek S, Elbatea H, El-Kalla F . Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis. Medicine (Baltimore). 2016; 95(23):e3853. PMC: 4907672. DOI: 10.1097/MD.0000000000003853. View